home.social

#technologytransfer — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #technologytransfer, aggregated by home.social.

  1. NASA-Supported Space Tech Advances Earthly Construction – NASA

    An innovative 3D printing process that advanced NASA’s approach to outfitting a lunar habitat is making buildings on…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Space #Science #Spinoffs #TechnologyTransfer #TechnologyTransfer&Spinoffs
    newsbeep.com/us/642388/

  2. NASA-Supported Space Tech Advances Earthly Construction – NASA

    An innovative 3D printing process that advanced NASA’s approach to outfitting a lunar habitat is making buildings on…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Space #Science #Spinoffs #TechnologyTransfer #TechnologyTransfer&Spinoffs
    newsbeep.com/us/642388/

  3. NASA-Supported Space Tech Advances Earthly Construction – NASA

    An innovative 3D printing process that advanced NASA’s approach to outfitting a lunar habitat is making buildings on…
    #NewsBeep #News #Space #CA #Canada #Science #Spinoffs #TechnologyTransfer #TechnologyTransfer&Spinoffs
    newsbeep.com/ca/667514/

  4. NASA-Supported Space Tech Advances Earthly Construction – NASA

    An innovative 3D printing process that advanced NASA’s approach to outfitting a lunar habitat is making buildings on…
    #NewsBeep #News #Space #Science #Spinoffs #TechnologyTransfer #TechnologyTransfer&Spinoffs #UK #UnitedKingdom
    newsbeep.com/uk/582506/

  5. 📢 PeCAHTS Abstracts Confirmed for Symposium K!

    ✍️ A diverse range of high-quality abstracts has been confirmed, covering cutting-edge research in photo and electrochemical systems for value-added synthesis.

    👉 More info: lnkd.in/d9itMB5h

    💡 It's shaping up to be an unmissable event for anyone in the field!

    #PeCATHS #Innovation #TechnologyTransfer #HydrogenStorage #EnergyTransition #HorizonEurope #SustainableEnergy

  6. 📢 PeCAHTS Abstracts Confirmed for Symposium K!

    ✍️ A diverse range of high-quality abstracts has been confirmed, covering cutting-edge research in photo and electrochemical systems for value-added synthesis.

    👉 More info: lnkd.in/d9itMB5h

    💡 It's shaping up to be an unmissable event for anyone in the field!

    #PeCATHS #Innovation #TechnologyTransfer #HydrogenStorage #EnergyTransition #HorizonEurope #SustainableEnergy

  7. Samsung Electronics declines Elon Musk's request for semiconductor production facility support, instead proposing expanded contract manufacturing through its Taylor, Texas foundry plant, maintaining cooperation while protecting core manufacturing technology amid $16.5 billion AI chip orders from Tesla.
    #YonhapInfomax #SamsungElectronics #Tesla #Terafab #FoundryManufacturing #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  8. Samsung Electronics declines Elon Musk's request for semiconductor production facility support, instead proposing expanded contract manufacturing through its Taylor, Texas foundry plant, maintaining cooperation while protecting core manufacturing technology amid $16.5 billion AI chip orders from Tesla.
    #YonhapInfomax #SamsungElectronics #Tesla #Terafab #FoundryManufacturing #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  9. Samsung Electronics declines Elon Musk's request for semiconductor production facility support, instead proposing expanded contract manufacturing through its Taylor, Texas foundry plant, maintaining cooperation while protecting core manufacturing technology amid $16.5 billion AI chip orders from Tesla.
    #YonhapInfomax #SamsungElectronics #Tesla #Terafab #FoundryManufacturing #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  10. Samsung Electronics declines Elon Musk's request for semiconductor production facility support, instead proposing expanded contract manufacturing through its Taylor, Texas foundry plant, maintaining cooperation while protecting core manufacturing technology amid $16.5 billion AI chip orders from Tesla.
    #YonhapInfomax #SamsungElectronics #Tesla #Terafab #FoundryManufacturing #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  11. D&D Pharmatech Co. revealed at the JP Morgan Healthcare Conference that it is in technology transfer talks with global pharmaceutical firms for DD01, its MASH therapy candidate, and plans to announce topline Phase 2 results in May.
    #YonhapInfomax #DDPharmatech #DD01 #MASH #TechnologyTransfer #JPmorganHealthcareConference #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  12. D&D Pharmatech Co. revealed at the JP Morgan Healthcare Conference that it is in technology transfer talks with global pharmaceutical firms for DD01, its MASH therapy candidate, and plans to announce topline Phase 2 results in May.
    #YonhapInfomax #DDPharmatech #DD01 #MASH #TechnologyTransfer #JPmorganHealthcareConference #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  13. D&D Pharmatech Co. revealed at the JP Morgan Healthcare Conference that it is in technology transfer talks with global pharmaceutical firms for DD01, its MASH therapy candidate, and plans to announce topline Phase 2 results in May.
    #YonhapInfomax #DDPharmatech #DD01 #MASH #TechnologyTransfer #JPmorganHealthcareConference #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  14. D&D Pharmatech Co. revealed at the JP Morgan Healthcare Conference that it is in technology transfer talks with global pharmaceutical firms for DD01, its MASH therapy candidate, and plans to announce topline Phase 2 results in May.
    #YonhapInfomax #DDPharmatech #DD01 #MASH #TechnologyTransfer #JPmorganHealthcareConference #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  15. Samjin Pharmaceutical is advancing the technology transfer of its chronic urticaria drug candidate SJN314, valued at 800 billion won ($610 million), with expectations for a share price revaluation and a strategic shift from generics to innovative drugs.
    #YonhapInfomax
    #SamjinPharmaceutical #SJN314 #TechnologyTransfer #ChronicUrticaria #ADCPlatform
    #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  16. Samjin Pharmaceutical is advancing the technology transfer of its chronic urticaria drug candidate SJN314, valued at 800 billion won ($610 million), with expectations for a share price revaluation and a strategic shift from generics to innovative drugs.
    #YonhapInfomax
    #SamjinPharmaceutical #SJN314 #TechnologyTransfer #ChronicUrticaria #ADCPlatform
    #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV